DANCR and breast carcinoma: First, DANCR was up‐regulated in breast tissues (specifically in those associated with advanced pathological grades or positive lymph node metastasis) as well as in highly malignant and metastatic TNBC cells, supporting the clinical relevance of DANCR in breast cancer.